Skip to main content

U.S. recommends pausing Johnson & Johnson vaccines to review rare blood clot

There have been six reports of blood clots of the 6.8 million vaccines given.

U.S. officials are recommending a "pause" in administering the Johnson & Johnson single-dose COVID-19 vaccine while they investigate six reports of severe blood clotting among the millions of people who have gotten the vaccine.  

In a joint statement on Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said out of the more than 6.8 million doses of the J&J vaccine that have been administered in the U.S., they're reviewing data involving six cases of a rare and severe type of blood clot called cerebral venous sinus thrombosis. 

These adverse events are "extremely rare," the statement says. The vast majority of people who have gotten the Johnson & Johnson vaccine have reported no or mild side effects. 

The six cases being investigated happened in women ages 18-48 with symptoms occurring 6-13 days after getting the shot. 

The statement notes the treatment for these blood clots is different than treatment for a normal blood clot, and using the typical treatment could be potentially "dangerous," so officials are recommending a "pause" in the use of the vaccine "out of an abundance of caution" so it can review treatment plans.

"This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot," the statement says. 

Anyone who develops a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after getting the Johnson & Johnson vaccine should contact their health care provider. Health care providers are then asked to report adverse events to the Vaccine Adverse Event Reporting System here

The CDC and FDA plan to hold a joint news conference at 9 a.m. that will be streamed live on YouTube here

The single-shot J&J vaccine is the newest vaccine available in the U.S., and is the least administered in Minnesota, comprising just 5% (166,326) of the total shots given, with Pfizer and Moderna doses comprising 51% and 44% respectively.

You can find out how to book a COVID-19 vaccine appointment here.

Next Up

Brave New Comedy Workshop in downtown Minneapolis.

Brave New Workshop cancels shows due to COVID-19 cases

The shows were scheduled for Friday and Saturday at the Brave New Workshop Comedy Theatre.

Austin Retterath

Body of missing U of M student found in Mississippi River

Austin Retterath was last seen alive in the morning hours of May 8.

"Love" mural seen in St. Paul.

Summer mural events to bring together community, shine light on MN artists

The 2022 Chroma Zone Mural & Art Festival will take place this weekend in St. Paul's Creative Enterprise Zone, with ensuing events happening this summer.


Gallery: Remodeled lakeside home in Prior Lake on market for $2.8M

It offers privacy at the end of a dead-end road fronting onto Lower Prior Lake.

golden valley police department

Carjacking outside ice arena in Golden Valley under investigation

Golden Valley PD confirmed it received a report of a carjacking Monday evening.


Signs that MN Legislature could move to loosen liquor laws

A provision was approved by a legislature committee on Thursday but still awaits a final decision from the House and Senate.

US Bank Stadium

U.S. Bank Stadium looking to hire 400 part-time workers

A hiring fair will be held for the positions.

Screen Shot 2022-05-20 at 8.55.56 AM

Officials looking for man last seen leaving Hudson home

David Mckay, 67, was last seen in Hudson Thursday morning.


'Hyper-contagious' BA.4, BA.5 COVID variants confirmed in MN

Omicron continues to evolve into a more transmissible virus.

covid-19, coronavirus

Minnesota's COVID-19 update for Friday, May 20

The latest data shows there are 442 people with COVID hospitalized in Minnesota.


covid, vaccine

Minnesota advises health providers pause Johnson & Johnson vaccines

Federal health officials have recommended the pause to review treatment of an extremely rare blot clot.

covid vaccine card

FDA gives full approval to Pfizer's COVID-19 vaccine

This approval is expected to lead to more vaccine mandates.

coronavirus, masks, covid-19

CDC: Fully vaccinated people don't have to wear masks outside

The CDC updated its COVID-19 guidance for vaccinated people on Tuesday.

covid-19, vaccine

Reports: FDA expected to OK use of Pfizer vaccine on young teens

Pfizer found its vaccine is very effective for people ages 12-15.


Walz: New COVID vaccine 'accelerates' state's vaccine rollout timeline

The governor said Wednesday the state will "significantly beat" its goal to vaccinate 70% of people 65 and older by the end of March.

covid, vaccine

MDH more focused on getting people vaccinated than wasting doses

Now that there's ample supply of the vaccine, health officials' focus has shifted.


Osterholm recommends delaying 2nd doses of COVID-19 vaccine

Delaying the second dose would allow more people to get a first dose of the vaccine.